, Tracking Stock Market Picks
Enter Symbol:

down 56.60 %

OREXIGEN THERAPEUTIC (OREX) rated Buy with price target $9 by WallachBeth

Posted on: Friday,  Jan 10, 2014  8:25 AM ET by WallachBeth

WallachBeth rated Buy OREXIGEN THERAPEUTIC (NASDAQ: OREX) on 01/10/2014, when the stock price was $6.36. Since
then, OREXIGEN THERAPEUTIC has lost 56.60% as of 12/11/2015's recent price of $2.76.
If you would have followed this WallachBeth's recommendation on OREX, you would have lost 56.6% of your investment in 700 days.

Orexigen Therapeutics, Inc. (Orexigen) is a biopharmaceutical company focused on the development of pharmaceutical product candidates for the treatment of obesity. The combination product candidates targeted for obesity are Contrave, which is in Phase III clinical trials, and Empatic, which is in the later stages of Phase II clinical development. Contrave is a fixed dose combination of naltrexone SR and bupropion SR. Empatic is a fixed dose combination of zonisamide SR and bupropion SR.

Stock Market Advice
Date/Time (ET)SymbolRatingTermPrice (*)Target
1/10/2014 8:25 AM Buy
6.36 9.00
as of 10/17/2014
1 Week up  18.95 %
1 Month down  -17.74 %
3 Months down  -19.04 %
1 YTD down  -35.84 %

(*) Stock Price at the time of the recommendation.
RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy